AbbVie, AbCellera expand collaboration into T-cell engagers
by Contributor since / Followers
1 day ago
AbbVie (NYSE:ABBV) and AbCellera (NASDAQ:ABCL) have expanded their collaboration to include the discovery of T-cell engagers for the treatment of cancer.
Under the deal, AbCellera (NASDAQ:ABCL) will lead discovery efforts, with AbbVie (NYSE:ABBV) retaining the right to